Method for the treatment of chronic pain
March 5, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod and composition of reducing pain Iontophoresis intermediary material and contact solution for the treatment of chronic pain syndromes Method of treating patients suffering from chronic pain or chronic cough Method of treating patients suffering from chronic pain or chronic cough (3S-4S)-7-hydroxy-Ɗ6 -tetrahydrocannabinols Treating autism and other developmental disorders in children with NMDA receptor antagonists Method for relieving chronic pain with a somatostatin analog composition Using NMDA receptor antagonists to reduce damage due to laser treatment Sialosyl cholesterol, process for producing the same, and neuropathy remedy comprising the same Tetrazole derivatives and aldose reductase inhibition therewith InventorsAssigneeApplicationNo. 027177 filed on 03/05/1993US Classes:514/289, Two of the cyclos share at least three ring members (i.e., bridged) (e.g., morphinans, etc.)514/647Amino nitrogen and a ring bonded directly to the same ring and any other amino nitrogen in the compound is bonded directly to one of the ringsExaminersPrimary: Cintins, Marianne M.Assistant: Jarvis, William R. A. Attorney, Agent or FirmInternational ClassA61K 031/485AbstractChronic pain is alleviated in a mammal suffering therefrom by administering to the mammal a chronic pain alleviating amount of a nontoxic N-methyl-D-aspartate receptor antagonist such as dextromethorphan, dextrorphan, ketamine or pharmaceutically acceptable salt thereof, alone or in combination with a local anesthetic and optionally in sustained release dosage form.Other References
| |
